Status:
COMPLETED
Helium-Hyperoxia and 6MWT Distance in COPD
Lead Sponsor:
University of Saskatchewan
Collaborating Sponsors:
Nova Scotia Health Authority
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
We assessed the effect of altering inspired gas on the 6MWT distance in COPD. We hypothesized that HeO2 would improve walking distance and reduce shortness of breath compared to both RA and O2, and po...
Detailed Description
We hypothesized that inspiring helium-hyperoxia (HeO2) would significantly improve 6-minute walking test (6MWT) distance in Chronic Obstructive Pulmonary Disease (COPD) subjects. This was a blinded, ...
Eligibility Criteria
Inclusion
- Exertional dyspnea
- Activity limitation
- COPD
Exclusion
- Recent exacerbation (\< 4 wks)
- Supplemental O2
- Significant cardiovascular/musculoskeletal abnormalities
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
End Date :
May 1 2006
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00394225
Start Date
July 1 2005
End Date
May 1 2006
Last Update
October 31 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Edmonton General Hospital, Caritas Lung HEalth Centre
Edmonton, Alberta, Canada